Suchergebnisse - "Shiotsu, Shinsuke"

PubPharm (7)

1

Clinical Efficacy and Safety of First- or Second-Generation EGFR-TKIs after Osimertinib Resistance for EGFR Mutated Lung Cancer : A Prospective Exploratory Study

enthalten in: Targeted oncology | 2023

von Morimoto, K. | Yamada, T. | Takeda, T. | +11

2

Predictive value of p53 and AXL immunostaining for the efficacy of immune checkpoint inhibitor-based therapy after osimertinib treatment in patients with epidermal growth factor-mutant non-small cell lung cancer

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Morimoto, K. | Yamada, T. | Sawada, R. | +15

3

High levels of AXL expression in untreated EGFR-mutated non-small cell lung cancer negatively impacts the use of osimertinib

enthalten in: Cancer science | 2023

von Yoshimura, A. | Yamada, T. | Serizawa, M. | +25

4

Impact of tumor programmed death ligand-1 expression on osimertinib efficacy in untreated EGFR-mutated advanced non-small cell lung cancer : a prospective observational study

enthalten in: Translational lung cancer research | 2021

von Yoshimura, A. | Yamada, T. | Okuma, Y. | +21

5

ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in EGFR-Mutated Non-Small Cell Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Okura, N. | Nishioka, N. | Yamada, T. | +19

6

Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation

enthalten in: Cancers | 2019

von Yoshimura, A. | Yamada, T. | Okura, N. | +10

7

AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells

enthalten in: Nature communications | 2019

von Taniguchi, H. | Yamada, T. | Wang, R. | +21

1
[1]